Home
Live Updates
Immutep : Corporate Presentation -March 26, 2024 at 08:12 am EDT : comparemela.com
Immutep : Corporate Presentation -March 26, 2024 at 08:12 am EDT
Forward-Looking Statements
The purpose of the presentation is to provide an update of the business of Immutep Limited ACN 009 237 889 . These slides have been...
Related Keywords
China ,
,
Immutep Limited ,
Nasdaq ,
Novartis ,
First In Class Lead ,
Nature Reviews Drug Discovery ,
Checkpoint Discovery ,
Approval Timeline ,
Chief Scientific Officer ,
Checkpoint Inhibitors ,
Asthma Reports ,
Major Histocompatibility Complex Class ,
Neck Squamous Cell Carcinoma ,
Non Small Cell Lung Cancer ,
Breast Cancer ,
Ulcerative Colitis ,
Investigator Initiated Trials ,
Stimulate Immune System ,
Immune Effect Leading ,
Positive Clinical ,
Year Survival ,
Combined Nivolumab ,
Advanced Melanoma ,
Untreated Advanced Melanoma ,
Markets ,
comparemela.com © 2020. All Rights Reserved.